This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
June 2024
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Brief Summary
The current standard technique is radiography requiring three uni- or bilateral punctures (transverse-axial plane). The ultrasound technique is also described mainly in this plan but a new "caudal-cranial" ultrasound-guided technique was described by Chang et al in 2018 in which the major axis is used to conduct the needle to the desired area. The investigators would like to confirm that this new technique in a single puncture is also possible under ultrasound.
Registry Overview
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Recruitment status
unknown
Estimated enrollment
40 participants
Study completion date
June 2024
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Listed locations
1 countries · 1 sites
Trial Relationships
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Related Scientific Literature
Loading related publications...
Study Timeline
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
Study Start
April 21, 2023
Actual (reported)
First Submitted
June 22, 2023
Actual (reported)
First Posted
July 5, 2023
Actual (reported)
Primary Completion
June 2024
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
June 2024
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
PainfluoroscopyUltrasoundInjection Site InfiltrationChronicfacet infiltration
Outcome Measures
Primary Outcomes (1)
Correct needle placement rate
Check the correct placement of the needle placed by caudal-cranial approach by X-ray to show if the placement is correct (at the same time)
0 min
Secondary Outcomes (2)
change in visual analog scale (VAS) pain score
30 min
Incidence of Adverse event
30 min
Study Arms (1)
ultrasound guided infiltration verified by fluoroscopy
EXPERIMENTAL
The 22G needle is introduced along a caudal-cranial axis to infiltrate at each level a volume of 1mL of a mixture consisting of 3mL of Linisol 2% (60mg of lidocaine) and 1mL of Depomedrol (Methylprednisolone) 40mg with 1mL of Omnipaque (contrast product). At each level, contrast medium will be injected at the same time as the linisol-depomedrol mixture so that once the BBM under ultrasound is completed, an X-ray check is performed.
The lumbar medial branch block on three lumbar levels (L3-L4, L4-L5 and L5-S1) will be performed by ultrasound-guidance in a longitudinal plane and the correct placement of the needle will be verified by radiography to show if the two modalities are equivalent.
Also known as: LMBB
ultrasound guided infiltration verified by fluoroscopy
LidocainDrug
Eligibility Criteria
Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
You may qualify if:
chronic low back pain compatible with facet lumbar syndrome with chronic pain of at least 3 months
who have not responded to conservative treatment after at least 4 weeks
Model Details: the medial branch block on three lumbar levels (L3-L4, L4-L5 and L5-S1) will be performed under ultrasound by "caudal-cranial" approach, followed by an X-ray check to verify the positioning of the needle.
Linisol infiltration with depomedrol and omnipaque
Also known as: linisol
ultrasound guided infiltration verified by fluoroscopy
MethylprednisoloneDrug
infiltration with linisol and omnipaque
Also known as: solumedrol
ultrasound guided infiltration verified by fluoroscopy
OmnipaqueDrug
infiltration with linisol and methylprednisolone
ultrasound guided infiltration verified by fluoroscopy
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
patients without signs of dissociated pain, radiculitis, neurological diseases including stroke and Parkinson's disease, spinal instability or deformities such as scoliosis, ankylosing spondylitis, history of lumbar surgery, fracture or lumbar tumor
You may not qualify if:
Pregnant or breastfeeding women
Allergy to injected products (Depomedrol or Linisol)
Psychiatric disorders hindering understanding of the protocol
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
June 2024
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
July 5, 2023
Record last verified: 2023-07
Data Sharing
IPD Sharing
Will not share
Source record
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.